Living with rheumatoid arthritis can feel like a constant negotiation with pain, stiffness and fatigue, but treatment can help you regain greater control. However, you don’t always have to rush directly to an operation. It begins with understanding what is driving your symptoms, how much joint damage has occurred and what you want to return to doing comfortably.
Biologic DMARDs may help control inflammation and slow further damage, while surgery may restore movement or reduce pain in a severely affected joint. Sometimes, both become part of the same treatment journey. This page explains where each option may fit, helping you work with your specialist towards a plan shaped around your condition, priorities and everyday life.
Rheumatoid arthritis treatment combines medication, lifestyle measures, physiotherapy and, when needed, surgery. The aims are to reduce inflammation, ease pain, prevent joint damage and preserve function. Most patients begin with conventional disease-modifying drugs (DMARDs), such as methotrexate. When these are not enough, doctors add biologic or targeted synthetic DMARDs. Surgery becomes part of the plan only when irreversible joint damage limits daily life.
Biologic DMARDs are advanced medicines that target specific parts of the immune system involved in rheumatoid arthritis. By blocking key inflammatory pathways, they control disease activity, ease symptoms and slow joint damage. They are usually given by injection or infusion, depending on the drug class.
Not every biologic works the same way. Each targets a different step in the immune process that drives rheumatoid arthritis. This variety helps because it offers options when the first choice doesn't work. The main classes include:
Which class fits depends on your disease pattern, other health conditions and how you respond. Your rheumatologist adjusts the choice over time. The aim is steady control while keeping side effects low.
Surgery is considered when joint damage is advanced and medical therapy can no longer control symptoms or restore function. Common reasons include severe joint pain, loss of mobility, deformity, mechanical instability, or tendon rupture. Surgery does not treat the autoimmune process itself, so medical therapy is usually continued afterwards. A rheumatologist and an orthopaedic surgeon in Mumbai with experience in inflammatory joint disease make decisions together. Knee involvement, sometimes called rheumatoid arthritis knee, is a common reason for joint replacement in this group.
Several procedures can help once damage is fixed. The right one depends on which joint is affected and how badly. The main surgical options include:
These surgical options are selected based on the extent of joint damage, symptom severity and functional limitation.
Biologic DMARDs and surgery are not competing choices. They do different jobs at different stages of the disease. The table below compares them.
For most people the two work in sequence, not opposition. Medicines control the disease first, and surgery repairs damage that is already done. Your care team helps you judge the timing.
Rheumatoid arthritis calls for early diagnosis, regular monitoring and joined-up care. At, Sir H. N. Reliance Foundation Hospital, this care comes from experienced rheumatology and orthopaedic teams. They see patients with ongoing joint pain, swelling, morning stiffness or symptoms that persist despite medication. For anyone seeking rheumatoid arthritis treatment in Mumbai, the care is comprehensive. It spans evaluation, imaging-based assessment, medical management, physiotherapy guidance and surgical planning when needed. The plan is shaped around your disease activity, your response to earlier medicines and your daily life.
Rheumatoid arthritis is a long-term condition, but it is far more manageable than it once was. For most people, conventional DMARDs come first, with biologics added when inflammation refuses to settle. Surgery plays a smaller, more targeted role, stepping in when damaged joints cause pain or limit movement. Steady, coordinated care and regular follow-up matter throughout. With the right plan, many people keep their joints working and stay active for years.
Many patients notice improvement within a few weeks of starting a biologic DMARD, with full benefit typically seen over three to six months. Response is monitored through clinical review and blood tests.
They are not always better. They are usually added when conventional DMARDs do not provide enough control. Conventional therapy remains the first step and is often continued alongside biologics.
Surgery does not cure rheumatoid arthritis because it does not alter the underlying autoimmune process. It restores function in damaged joints and reduces pain, while disease-modifying treatment continues.
Recovery varies with the procedure and joint. Joint replacement typically requires several weeks of rehabilitation. Most patients return to normal activity within a few months with structured physiotherapy.
Yes. Knee replacement is a well-established surgical option for advanced RA-related knee damage. Pain relief and improved mobility are usually significant.
Surgery treats the affected joint, but the underlying disease remains active. Ongoing medical therapy is therefore essential to control disease activity and protect other joints.
Disclaimer:
This article is for general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified specialist or healthcare professional regarding any medical condition or treatment decision.
Medically Reviewed By: Dr. Vaibhav Bagaria , Director - Department of Orthopaedics & Joint Replacement , Sir H. N. Reliance Foundation Hospital